Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol.

We thus suggest that ceramides- and phosphatidylcholine-based predictors rather than LDL-C may be used for a more accurate cardiovascular risk prediction in high-risk patients.